Product Information

ESCITALOPRAM 15 MG CAPSULE is a generic product labeled by Almatica Pharma LLC, priced at $5.6030 per EA under NDC 52427079530. Its NADAC has been published 40 times since Feb 18, 2026.

FDA first approved this application on Aug 29, 2025.

The High Outlier badge above means this manufacturer's average price in the escitalopram market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ESCITALOPRAM 15 MG CAPSULE

escitalopram
$5.6030per EA
High Outlier

Strength

15 mg/1

NDC

52427079530

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ESCITALOPRAM OXALATE

Approval Type

New Drug (NDA)

FDA Application

NDA219130

FDA Approved

8/29/2025

On Market Since

10/6/2025

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for ESCITALOPRAM 15 MG CAPSULE has been published 40 times since Feb 18, 2026, and over the history we have for it it has risen 3.4%. The table below summarizes its recorded NADAC range and movement.

Current price$5.6030 per EA
All-time high$5.6030 (Nov 18, 2026)
All-time low$5.4075 (Aug 19, 2026)
52-week high$5.6030
52-week low$5.4075
Median price$5.4232
Average price$5.4359
Largest weekly change+1.6% (Nov 18, 2026)
Weeks tracked40
Tracking sinceFeb 18, 2026

Price History

1W

+1.6%

1M

+2.7%

3M

+3.6%

6M

+3.3%

1Y

N/A

3Y

N/A

5Y

N/A

All

+3.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the escitalopram market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ESCITALOPRAM 15 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 15 MG CAPSULE, manufactured by Almatica Pharma LLC, is $5.6030 per EA (NDC 52427079530), effective Nov 18, 2026.

How has the price of ESCITALOPRAM 15 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ESCITALOPRAM 15 MG CAPSULE has risen 3.4%. It has been tracked across 40 weekly CMS publications since Feb 18, 2026.

What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 15 MG CAPSULE?

Since Feb 18, 2026, the NADAC for ESCITALOPRAM 15 MG CAPSULE has ranged from a low of $5.4075 (Aug 19, 2026) to a high of $5.6030 (Nov 18, 2026), with a median of $5.4232 per EA.

Are there cheaper alternatives to ESCITALOPRAM 15 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of ESCITALOPRAM 15 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ESCITALOPRAM 15 MG CAPSULE?

ESCITALOPRAM 15 MG CAPSULE (NDC 52427079530) is labeled by Almatica Pharma LLC, and CMS classifies it as a generic product.